The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Prostate Specific Antigen Best Practice Statement: 2009 Update
Abstract
PURPOSE: We provide current information on the use of PSA testing for the evaluation of men at risk for prostate cancer, and the risks and benefits of early detection. MATERIALS AND METHODS: The report is a summary of the American Urological Association PSA Best Practice Policy 2009. The summary statement is based on a review of the current professional literature, clinical experience and the expert opinions of a multispecialty panel. It is intended to serve as a resource for physicians, other health care professionals, and patients. It does not establish a fixed set of guidelines, define the legal standard of care or pre-empt physician judgment in individual cases. RESULTS: There are two notable differences in the current policy. First, the age for obtaining a baseline PSA has been lowered to 40 years. Secondly, the current policy no longer recommends a single, threshold value of PSA, which should prompt prostate biopsy. Rather, the decision to proceed to prostate biopsy should be based primarily on PSA and DRE results, but should take into account multiple factors including free and total PSA, patient age, PSA velocity, PSA density, family history, ethnicity, prior biopsy history and comorbidities. CONCLUSIONS: Although recently published trials show different results regarding the impact of prostate cancer screening on mortality, both suggest that prostate cancer screening leads to overdetection and overtreatment of some patients. Therefore, men should be informed of the risks and benefits of prostate cancer screening before biopsy and the option of active surveillance in lieu of immediate treatment for certain men diagnosed with prostate cancer.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
Tannock, I. F., de Wit, R., Berry, W. R., Horti, J., Pluzanska, A., Chi, K. N., Oudard, S., Théodore, C., James, N. D., Turesson, I., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040720 · Cited by 5,735
Screening and Prostate-Cancer Mortality in a Randomized European Study
Schröder, F. H., Hugosson, J., Roobol, M. J., Tammela, T. L. J., Ciatto, S., Nelen, V., Kwiatkowski, M., Lujan, M., Lilja, H., Zappa, M., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810084 · Cited by 4,014
Petrylak, D. P., Tangen, C. M., Hussain, M. H. A., Lara, P. N., Jones, J. A., Taplin, M. E., Burch, P. A., Berry, D., Moinpour, C., Kohli, M., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041318 · Cited by 3,665
Mortality Results from a Randomized Prostate-Cancer Screening Trial
Andriole, G. L., Crawford, E. D., Grubb, R. L., Buys, S. S., Chia, D., Church, T. R., Fouad, M. N., Gelmann, E. P., Kvale, P. A., Reding, D. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810696 · Cited by 2,906
Roach, M., Hanks, G., Thames, H., Schellhammer, P., Shipley, W. U., Sokol, G. H., & Sandler, H. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.04.029 · Cited by 2,749
SEER Cancer Statistics Review, 1975-2008, National Cancer Institute, Bethesda, MD
Howlader, N. (2011) · Medical Entomology and Zoology · Cited by 2,612
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
The Influence of Finasteride on the Development of Prostate Cancer
Thompson, I. M., Goodman, P. J., Tangen, C. M., Lucia, M. S., Miller, G. J., Ford, L. G., Lieber, M. M., Cespedes, R. D., Atkins, J. N., Lippman, S. M., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa030660 · Cited by 2,518
Thompson, I. M., Pauler, D. K., Goodman, P. J., Tangen, C. M., Lucia, M. S., Parnes, H. L., Minasian, L. M., Ford, L. G., Lippman, S. M., Crawford, E. D., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031918 · Cited by 2,446
Quality of Life and Satisfaction with Outcome among Prostate-Cancer Survivors
Sanda, M. G., Dunn, R. L., Michalski, J., Sandler, H. M., Northouse, L., Hembroff, L., Lin, X., Greenfield, T. K., Litwin, M. S., Saigal, C. S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa074311 · Cited by 2,253
Self-citationMetabolomic profiles delineate potential role for sarcosine in prostate cancer progression
Sreekumar, A., Poisson, L. M., Rajendiran, T. M., Khan, A. P., Cao, Q., Yu, J., Laxman, B., Mehra, R., Lonigro, R. J., Li, Y., et al. (2009) · Nature · doi:10.1038/nature07762 · Cited by 2,234
Sathianathen, N. (2021) · 50 Studies Every Urologist Should Know · doi:10.1093/med/9780190655341.003.0002 · Cited by 2,080
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Garmo, H., Stark, J. R., Busch, C., Nordling, S., Häggman, M., Andersson, S.-O., Bratell, S., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1011967 · Cited by 1,900
Partin, A. W. (1997) · JAMA · doi:10.1001/jama.277.18.1445 · Cited by 1,794
Freedland, S. J., Humphreys, E. B., Mangold, L. A., Eisenberger, M., Dorey, F. J., Walsh, P. C., & Partin, A. W. (2005) · JAMA · doi:10.1001/jama.294.4.433 · Cited by 1,358
Partin, A. W., Yoo, J., Carter, H. B., Pearson, J. D., Chan, D. W., Epstein, J. I., & Walsh, P. C. (1993) · Journal of Urology · doi:10.1016/s0022-5347(17)35410-1 · Cited by 1,278
Self-citationOesterling, J. E. (1993) · JAMA · doi:10.1001/jama.270.7.860 · Cited by 1,266
A Preoperative Nomogram for Disease Recurrence Following Radical Prostatectomy for Prostate Cancer
Kattan, M. W., Eastham, J. A., Stapleton, A. M. F., Wheeler, T. M., & Scardino, P. T. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.10.766 · Cited by 1,242
Oesterling, J. E. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)38491-4 · Cited by 1,230
Messing, E. M., Manola, J., Sarosdy, M., Wilding, G., Crawford, E. D., & Trump, D. (1999) · New England Journal of Medicine · doi:10.1056/nejm199912093412401 · Cited by 1,191
20-Year Outcomes Following Conservative Management of Clinically Localized Prostate Cancer
Albertsen, P. C. (2005) · JAMA · doi:10.1001/jama.293.17.2095 · Cited by 1,187
Self-citationCatalona, W. J., Partin, A. W., Slawin, K. M., Brawer, M. K., Flanigan, R. C., Patel, A., Richie, J. P., deKernion, J. B., Walsh, P. C., Scardino, P. T., et al. (1998) · JAMA · doi:10.1001/jama.279.19.1542 · Cited by 1,162
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
Thompson, I., Thrasher, J. B., Aus, G., Burnett, A. L., Canby-Hagino, E. D., Cookson, M. S., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.003 · Cited by 1,113
Radical Prostatectomy versus Watchful Waiting in Early Prostate Cancer
Bill-Axelson, A., Holmberg, L., Ruutu, M., Häggman, M., Andersson, S.-O., Bratell, S., Spångberg, A., Busch, C., Nordling, S., Garmo, H., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043739 · Cited by 1,111
Longitudinal Evaluation of Prostate-Specific Antigen Levels in Men With and Without Prostate Disease
Carter, H. B. (1992) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1992.03480160073037 · Cited by 1,096
Self-citationDraisma, G., Boer, R., Otto, S. J., van der Cruijsen, I. W., Damhuis, R. A. M., Schroder, F. H., & de Koning, H. J. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.12.868 · Cited by 1,071
Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium
Partin, A. W., Mangold, L. A., Lamm, D. M., Walsh, P. C., Epstein, J. I., & Pearson, J. D. (2001) · Urology · doi:10.1016/s0090-4295(01)01441-8 · Cited by 1,038
Han, M., Partin, A. W., Pound, C. R., Epstein, J. I., & Walsh, P. C. (2001) · Urologic Clinics of North America · doi:10.1016/s0094-0143(05)70163-4 · Cited by 1,028
Self-citationEtzioni, R. (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.13.981 · Cited by 949
Assessing Prostate Cancer Risk: Results from the Prostate Cancer Prevention Trial
Thompson, I. M., Ankerst, D. P., Chi, C., Goodman, P. J., Tangen, C. M., Lucia, M. S., Feng, Z., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj131 · Cited by 938
Results of Conservative Management of Clinically Localized Prostate Cancer
Chodak, G. W., Thisted, R. A., Gerber, G. S., Johansson, J.-E., Adolfsson, J., Jones, G. W., Chisholm, G. D., Moskovitz, B., Livne, P. M., & Warner, J. (1994) · New England Journal of Medicine · doi:10.1056/nejm199401273300403 · Cited by 928
Stephenson, A. J., Scardino, P. T., Kattan, M. W., Pisansky, T. M., Slawin, K. M., Klein, E. A., Anscher, M. S., Michalski, J. M., Sandler, H. M., Lin, D. W., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.08.9607 · Cited by 888
Self-citationROEHL, K. A., HAN, M., RAMOS, C. G., ANTENOR, J. A. V., & CATALONA, W. J. (2004) · Journal of Urology · doi:10.1097/01.ju.0000134888.22332.bb · Cited by 861
Self-citationCookson, M. S., Aus, G., Burnett, A. L., Canby-Hagino, E. D., D’Amico, A. V., Dmochowski, R. R., Eton, D. T., Forman, J. D., Goldenberg, S. L., Hernandez, J., et al. (2007) · Journal of Urology · doi:10.1016/j.juro.2006.10.097 · Cited by 844
Stamey, T. A., Freiha, F. S., McNeal, J. E., Redwine, E. A., Whittemore, A. S., & Schmid, H.-P. (1993) · Cancer · doi:10.1002/1097-0142(19930201)71:3+<933::aid-cncr2820711408>3.0.co;2-l · Cited by 799
COOPERBERG, M. R., PASTA, D. J., ELKIN, E. P., LITWIN, M. S., LATINI, D. M., Du CHANE, J., & CARROLL, P. R. (2005) · Journal of Urology · doi:10.1097/01.ju.0000158155.33890.e7 · Cited by 772
Self-citationPreoperative PSA Velocity and the Risk of Death from Prostate Cancer after Radical Prostatectomy
D'Amico, A. V., Chen, M.-H., Roehl, K. A., & Catalona, W. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032975 · Cited by 740
Albertsen, P. C. (1998) · JAMA · doi:10.1001/jama.280.11.975 · Cited by 717
Self-citationThompson, I. M. (2005) · JAMA · doi:10.1001/jama.294.1.66 · Cited by 704
Natural History of Early, Localized Prostate Cancer
Johansson, J.-E. (2004) · JAMA · doi:10.1001/jama.291.22.2713 · Cited by 703
The Role of Increasing Detection in the Rising Incidence of Prostate Cancer
Potosky, A. L. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310046028 · Cited by 674
Trock, B. J. (2008) · JAMA · doi:10.1001/jama.299.23.2760 · Cited by 657
Hankey, B. F., Feuer, E. J., Clegg, L. X., Hayes, R. B., Legler, J. M., Prorok, P. C., Ries, L. A., Merrill, R. M., & Kaplan, R. S. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.12.1017 · Cited by 652
Imaging Prostate Cancer: A Multidisciplinary Perspective
Hricak, H., Choyke, P. L., Eberhardt, S. C., Leibel, S. A., & Scardino, P. T. (2007) · Radiology · doi:10.1148/radiol.2431030580 · Cited by 601
PROSTATE SPECIFIC ANTIGEN: A DECADE OF DISCOVERY-WHAT WE HAVE LEARNED AND WHERE WE ARE GOING
POLASCIK, T. J., OESTERLING, J. E., & PARTIN, A. W. (1999) · Journal of Urology · doi:10.1016/s0022-5347(05)68543-6 · Cited by 599
Epstein, J. I., Partin, A. W., Sauvageot, J., & Walsh, P. C. (1996) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199603000-00004 · Cited by 562
Carter, H. B., Ferrucci, L., Kettermann, A., Landis, P., Wright, E. J., Epstein, J. I., Trock, B. J., & Metter, E. J. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj410 · Cited by 556
Self-citationStephenson, A. J., Kattan, M. W., Eastham, J. A., Dotan, Z. A., Bianco, F. J., Lilja, H., & Scardino, P. T. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.0756 · Cited by 529
Hussain, M., Tangen, C. M., Higano, C., Schelhammer, P. F., Faulkner, J., Crawford, E. D., Wilding, G., Akdas, A., Small, E. J., Donnelly, B., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.4246 · Cited by 505
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
U.S. Preventive Services Task Force* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-3-200808050-00008 · Cited by 505
Long-term Survival Among Men With Conservatively Treated Localized Prostate Cancer
Albertsen, P. C. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03530080042039 · Cited by 464
Self-citationContemporary Trends in Low Risk Prostate Cancer: Risk Assessment and Treatment
Cooperberg, M. R., Broering, J. M., Kantoff, P. W., & Carroll, P. R. (2007) · Journal of Urology · doi:10.1016/j.juro.2007.03.135 · Cited by 442
Self-citationSTEWART, C. S., Leibovich, B. C., Weaver, A. L., & Lieber, M. M. (2001) · The Journal of Urology · doi:10.1016/s0022-5347(05)66083-1 · Cited by 438
Quantifying the role of PSA screening in the US prostate cancer mortality decline
Etzioni, R., Tsodikov, A., Mariotto, A., Szabo, A., Falcon, S., Wegelin, J., diTommaso, D., Karnofski, K., Gulati, R., Penson, D. F., et al. (2008) · Cancer Causes & Control · doi:10.1007/s10552-007-9083-8 · Cited by 423
Age-Specific Reference Ranges for Serum Prostate-Specific Antigen in Black Men
Morgan, T. O., Jacobsen, S. J., McCarthy, W. F., Jacobson, D. J., McLeod, D. G., & Moul, J. W. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608013350502 · Cited by 412
The Clinical Usefulness of Prostate Specific Antigen: Update 1994
Partin, A. W., & Oesterling, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)32422-9 · Cited by 390
Prostate Cancer and the Will Rogers Phenomenon
Albertsen, P. C., Hanley, J. A., Barrows, G. H., Penson, D. F., Kowalczyk, P. D. H., Sanders, M. M., & Fine, J. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji248 · Cited by 382
Self-citationSirovich, B. E., Schwartz, L. M., & Woloshin, S. (2003) · JAMA · doi:10.1001/jama.289.11.1414 · Cited by 369
Freedland, S. J., Humphreys, E. B., Mangold, L. A., Eisenberger, M., Dorey, F. J., Walsh, P. C., & Partin, A. W. (2006) · Journal of Urology · doi:10.1016/s0022-5347(05)00388-5 · Cited by 339
ANATOMICAL EXTENT OF LYMPH NODE DISSECTION: IMPACT ON MEN WITH CLINICALLY LOCALIZED PROSTATE CANCER
ALLAF, M. E., PALAPATTU, G. S., TROCK, B. J., CARTER, H. B., & WALSH, P. C. (2004) · Journal of Urology · doi:10.1097/01.ju.0000140912.45821.1d · Cited by 338
Self-citationGeographic pathology of latent prostatic carcinoma
Yatani, R., Chigusa, I., Akazaki, K., Stemmermann, G. N., Welsh, R. A., & Correa, P. (1982) · International Journal of Cancer · doi:10.1002/ijc.2910290602 · Cited by 325
Effect of Finasteride on the Sensitivity of PSA for Detecting Prostate Cancer
Thompson, I. M., Chi, C., Ankerst, D. P., Goodman, P. J., Tangen, C. M., Lippman, S. M., Lucia, M. S., Parnes, H. L., & Coltman, C. A. (2006) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djj307 · Cited by 323
D’Amico, A. V., Renshaw, A. A., Sussman, B., & Chen, M.-H. (2005) · JAMA · doi:10.1001/jama.294.4.440 · Cited by 323
Borboroglu, P. G., COMER, S. W., Riffenburgh, R. H., & Amling, C. L. (2000) · The Journal of Urology · doi:10.1016/s0022-5347(05)67994-3 · Cited by 321
Bartsch, G., Horninger, W., Klocker, H., Reissigl, A., Oberaigner, W., Schönitzer, D., Severi, G., Robertson, C., & Boyle, P. (2001) · Urology · doi:10.1016/s0090-4295(01)01264-x · Cited by 315
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Wong, Y.-N., Mitra, N., Hudes, G., Localio, R., Schwartz, J. S., Wan, F., Montagnet, C., & Armstrong, K. (2006) · JAMA · doi:10.1001/jama.296.22.2683 · Cited by 305
Prostate Cancer: A Current Perspective
Nomura, A. M. Y., & Kolonel, L. N. (1991) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036069 · Cited by 301
Estimating Treatment Benefits for the Elderly: The Effect of Competing Risks
Welch, H. G., Albertsen, P. C., Nease, R. F., Bubolz, T. A., & Wasson, J. H. (1996) · Annals of Internal Medicine · doi:10.7326/0003-4819-124-6-199603150-00007 · Cited by 281
Self-citationArmstrong, A. J., Garrett-Mayer, E., Ou Yang, Y.-C., Carducci, M. A., Tannock, I., de Wit, R., & Eisenberger, M. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.4769 · Cited by 275
Kane, C. J., Amling, C. L., Johnstone, P. A. S., Pak, N., Lance, R. S., Thrasher, J. B., Foley, J. P., Riffenburgh, R. H., & Moul, J. W. (2003) · Urology · doi:10.1016/s0090-4295(02)02411-1 · Cited by 274
Active surveillance for early‐stage prostate cancer: Review of the current literature
Dall'Era, M. A., Cooperberg, M. R., Chan, J. M., Davies, B. J., Albertsen, P. C., Klotz, L. H., Warlick, C. A., Holmberg, L., Bailey, D. E., Wallace, M. E., et al. (2008) · Cancer · doi:10.1002/cncr.23373 · Cited by 273
Self-citationPSA Screening Among Elderly Men With Limited Life Expectancies
Walter, L. C., Bertenthal, D., Lindquist, K., & Konety, B. R. (2006) · JAMA · doi:10.1001/jama.296.19.2336 · Cited by 262
Eliminating the Need for Bilateral Pelvic Lymphadenectomy in Select Patients with Prostate Cancer
Bluestein, D. L., Bostwick, D. G., Bergstralh, E. J., & Oesterling, J. E. (1994) · Journal of Urology · doi:10.1016/s0022-5347(17)35239-4 · Cited by 254
Vickers, A. J., Savage, C., O'Brien, M. F., & Lilja, H. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.1685 · Cited by 254
Vickers, A. J., Cronin, A. M., Aus, G., Pihl, C.-G., Becker, C., Pettersson, K., Scardino, P. T., Hugosson, J., & Lilja, H. (2008) · BMC Medicine · doi:10.1186/1741-7015-6-19 · Cited by 249
Moul, J. W., Wu, H., Sun, L., McLeod, D. G., Amling, C., Donahue, T., Kusuda, L., Sexton, W., O’Reilly, K., Hernandez, J., et al. (2008) · Journal of Urology · doi:10.1016/j.juro.2008.03.138 · Cited by 247
Andriole, G. L., Levin, D. L., Crawford, E. D., Gelmann, E. P., Pinsky, P. F., Chia, D., Kramer, B. S., Reding, D., Church, T. R., Grubb, R. L., et al. (2005) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/dji065 · Cited by 244
Screening for Prostate Cancer with Prostate-Specific Antigen — An Examination of the Evidence
Woolf, S. H. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511233332107 · Cited by 240
Richie, J. P., Catalona, W. J., Ahmann, F. R., Hudson, M. A., Scardino, P. T., Flanigan, R. C., Dekernion, J. B., Ratliff, T. L., Kavoussi, L. R., Dalkin, B. L., et al. (1993) · Urology · doi:10.1016/0090-4295(93)90359-i · Cited by 230
Biomarkers for Prostate Cancer
Makarov, D. V., Loeb, S., Getzenberg, R. H., & Partin, A. W. (2009) · Annual Review of Medicine · doi:10.1146/annurev.med.60.042307.110714 · Cited by 219
Andriole, G. L., Guess, H. A., Epstein, J. I., Wise, H., Kadmon, D., Crawford, E. D., Hudson, P., Jackson, C. L., Romas, N. A., Patterson, L., et al. (1998) · Urology · doi:10.1016/s0090-4295(98)00184-8 · Cited by 202
Loeb, S., Roehl, K. A., Antenor, J. A. V., Catalona, W. J., Suarez, B. K., & Nadler, R. B. (2006) · Urology · doi:10.1016/j.urology.2005.08.040 · Cited by 184
Wolf, J. S., Cher, M. L., Dall’Era, M., Presti, J. C., Hricak, H., & Carroll, P. R. (1995) · PubMed · Cited by 181
Self-citationAssessing Individual Risk for Prostate Cancer
Nam, R. K., Toi, A., Klotz, L. H., Trachtenberg, J., Jewett, M. A. S., Appu, S., Loblaw, D. A., Sugar, L., Narod, S. A., & Kattan, M. W. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.10.6450 · Cited by 176
Recommended Prostate-Specific Antigen Testing Intervals for the Detection of Curable Prostate Cancer
Carter, H. B. (1997) · JAMA · doi:10.1001/jama.1997.03540420052029 · Cited by 167
Self-citationMiller, J. I., Ahmann, F. R., Drach, G. W., Emerson, S. S., & Bottaccini, M. R. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37432-3 · Cited by 163
Ross, K. S. (2000) · JAMA · doi:10.1001/jama.284.11.1399 · Cited by 161
Nelson, E. D., Slotoroff, C. B., Gomella, L. G., & Halpern, E. J. (2007) · Urology · doi:10.1016/j.urology.2007.07.067 · Cited by 158
The Prevalence of Prostate Carcinoma and Its Precursor in Hungary: An Autopsy Study
Soós, G., TSAKIRIS, I., Szántó, J., Turzó, C., Haas, P., & Dezsö, B. (2005) · European Urology · doi:10.1016/j.eururo.2005.08.010 · Cited by 154
Sanderson, K. M., Penson, D. F., Cai, J., Groshen, S. G., Stein, J. P., Lieskovsky, G., & Skinner, D. G. (2006) · The Journal of Urology · doi:10.1016/j.juro.2006.07.075 · Cited by 137
Update: NCCN prostate cancer Clinical Practice Guidelines.
Scardino, P. T. (2005) · PubMed · Cited by 136
Prevalence of Incidental Prostate Cancer in the General Population: A Study of Healthy Organ Donors
Yin, M., Bastacky, S., Chandran, U. R., Becich, M. J., & Dhir, R. (2008) · The Journal of Urology · doi:10.1016/j.juro.2007.10.057 · Cited by 128
Active surveillance with selective delayed intervention for favorable risk prostate cancer
Klotz, L. H. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.07.002 · Cited by 119
Comparison of biochemical failure definitions for permanent prostate brachytherapy
Kuban, D. A., Levy, L. B., Potters, L., BEYER, D. C., Blasko, J. C., Moran, B. J., Ciezki, J. P., Zietman, A. L., Zeléfsky, M. J., Pisansky, T. M., et al. (2006) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2006.03.027 · Cited by 118
Self-citationLymph node size does not correlate with the presence of prostate cancer metastasis
Tiguert, R., Gheiler, E. L., Tefilli, M. V., Oskanian, P., Banerjee, M., Grignon, D. J., Sakr, W., Pontes, J. E., & Wood, D. P. (1999) · Urology · doi:10.1016/s0090-4295(98)00518-4 · Cited by 116
Bishoff, J. T., Reyes, A., Thompson, I. M., Harris, M. J., Clair, S. R. S., Gomella, L. G., & Butzin, C. A. (1995) · Urology · doi:10.1016/0090-4295(95)80017-4 · Cited by 115
Golgi Protein GOLM1 Is a Tissue and Urine Biomarker of Prostate Cancer
Varambally, S., Laxman, B., Mehra, R., Cao, Q., Dhanasekaran, S. M., Tomlins, S. A., Granger, J. I., Vellaichamy, A., Sreekumar, A., Yu, J., et al. (2008) · Neoplasia · doi:10.1593/neo.08922 · Cited by 111
Etzioni, R., Gulati, R., Falcon, S., & Penson, D. F. (2008) · Medical Decision Making · doi:10.1177/0272989x07312719 · Cited by 105
Hattab, E. M., Koch, M. O., Eble, J. N., Lin, H., & Liang Cheng, C. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00998-5 · Cited by 102
Stewart, A., Scher, H. I., Chen, M., McLeod, D. G., Carroll, P. R., Moul, J. W., & D'Amico, A. V. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.20.966 · Cited by 100
Self-citationNarayan, P. A., Fournier, G. R., Gajendran, V., Leidich, R. B., Lo, R., Wolf, J. S., Jacob, G., Nicolaisen, G. S., Palmer, K., & Freina, F. (1994) · Urology · doi:10.1016/s0090-4295(94)80050-2 · Cited by 99
Sartor, O., Weinberger, M., Moore, A., Li, A., & Figg, W. D. (1998) · Urology · doi:10.1016/s0090-4295(98)00149-6 · Cited by 93
Prostate Specific Antigen Recurrence After Definitive Therapy
Freedland, S. J., & Moul, J. W. (2007) · The Journal of Urology · doi:10.1016/j.juro.2007.01.137 · Cited by 91
Evidence to Support a Continued Stage Migration and Decrease in Prostate Cancer Specific Mortality
Galper, S. L., Chen, M., Catàlona, W. J., Roehl, K. A., Richie, J. P., & D'Amico, A. V. (2006) · The Journal of Urology · doi:10.1016/s0022-5347(05)00419-2 · Cited by 91
DAVIDCRAWFORD, E., DeAntoni, E. P., Etzioni, R., Schaefer, V., OLSON, R., & Ross, C. W. (1996) · Urology · doi:10.1016/s0090-4295(96)00061-1 · Cited by 88
Small, E. J., McMillan, A., Meyer, M., Chen, L., Slichenmyer, W. J., Lenehan, P. F., & Eisenberger, M. A. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1304 · Cited by 83
Fowler, F. J., Barry, M. J., Walker-Corkery, B., Caubet, J.-F., Bates, D. W., Lee, J. M., Hauser, A., & McNaughton‐Collins, M. (2006) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2006.00464.x · Cited by 79
Burdick, M. J., Reddy, C. A., ULCHAKER, J. C., Angermeier, K. W., ALTMAN, A. L., Chehade, N. E. H., Mahadevan, A., Kupelian, P. A., Klein, E. A., & Ciezki, J. P. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2008.07.033 · Cited by 64
Hugosson, J., Aus, G., Lilja, H. G., Lodding, P., Pihl, C. G., & Pileblad, E. (2003) · The Journal of Urology · doi:10.1097/01.ju.0000061183.43229.2e · Cited by 64
Endoglin (CD105) as a urinary and serum marker of prostate cancer
Fujita, K., Ewing, C. M., Chan, D. Y. S., Mangold, L. A., Partin, A. W., Isaacs, W. B., & Pavlovich, C. P. (2008) · International Journal of Cancer · doi:10.1002/ijc.24007 · Cited by 62
MR Imaging and MR Spectroscopy in Prostate Cancer Management
Katz, S. I., & Rosen, M. A. (2006) · Radiologic Clinics of North America · doi:10.1016/j.rcl.2006.07.008 · Cited by 61
Adjuvant Radiotherapy for Patients with Locally Advanced Prostate Cancer—A New Standard?
Ganswindt, U., Stenzl, A., Bamberg, M., & Belka, C. (2008) · European Urology · doi:10.1016/j.eururo.2008.06.059 · Cited by 45
Prostate-Specific Antigen and Digital Rectal Examination in Screening for Prostate Cancer
Bretton, P. R. (1994) · Southern Medical Journal · doi:10.1097/00007611-199407000-00009 · Cited by 42
Feuer, E. J., Etzioni, R., Cronin, K. A., et al. (2004) · Statistical Methods in Medical Research · doi:10.1191/0962280204sm376ra · Cited by 41
Gosselaar, C., Roobol, M. J., Roemeling, S., de Vries, S. H., van der Cruijsen‐Koeter, I., van der Kwast, T., & Schröder, F. H. (2005) · The Prostate · doi:10.1002/pros.20359 · Cited by 35
The role of lymphadenectomy in prostate cancer
Burkhard, F. C., Schumacher, M. C., & Studer, U. E. (2005) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0245 · Cited by 34
Serum PSA and Percent Free PSA Value Changes after Antibiotic Treatment
Kobayashi, M., Nukui, A., & Morita, T. (2008) · Urologia Internationalis · doi:10.1159/000112612 · Cited by 34
Prognostic Markers Under Watchful Waiting and Radical Prostatectomy
Holmberg, L., Bill‐Axelson, A., Garmo, H., Palmgren, J., Norlén, B. J., Adami, H., & Johansson, J. E. (2006) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2006.03.007 · Cited by 31
Murphy, G. P., Snow, P. B., Brandt, J. M., Elgamal, A., & Brawer, M. K. (2000) · The Prostate · Cited by 30
The responsible use of antibiotics for an elevated PSA level
Scardino, P. T. (2007) · Nature Clinical Practice Urology · doi:10.1038/ncpuro0702 · Cited by 30
Robinson, D., Sandblom, G., Johansson, R., Garmo, H., Aus, G., Hedlund, P. O., & Varenhorst, E. (2008) · Urology · doi:10.1016/j.urology.2008.05.026 · Cited by 20
Screening for carcinoma of the prostate with prostate specific antigen.
Muschenheim, F., Omarbasha, B., Kardjian, P., & Mondou, E. (1991) · PubMed · Cited by 20
Cited by
Screening for Prostate Cancer: U.S. Preventive Services Task Force Recommendation Statement
Moyer, V. A., & on behalf of the U.S. Preventive Services Task Force* (2012) · Annals of Internal Medicine · doi:10.7326/0003-4819-157-2-201207170-00459 · Cited by 2,522
Bhasin, S., Cunningham, G. R., Hayes, F. J., Matsumoto, A. M., Snyder, P. J., Swerdloff, R. S., & Montori, V. M. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2354 · Cited by 1,954
American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010
Wolf, A. M. D., Wender, R. C., Etzioni, R. B., Thompson, I. M., D'Amico, A. V., Volk, R. J., Brooks, D. D., Dash, C., Guessous, I., Andrews, K., et al. (2010) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20066 · Cited by 965
Ficarra, V., Novara, G., Ahlering, T. E., Costello, A., Eastham, J. A., Graefen, M., Guazzoni, G., Menon, M., Mottrie, A., Patel, V. R., et al. (2012) · European Urology · doi:10.1016/j.eururo.2012.05.046 · Cited by 786
Screening for Prostate Cancer: A Review of the Evidence for the U.S. Preventive Services Task Force
Chou, R., Croswell, J. M., Dana, T., Bougatsos, C., Blazina, I., Fu, R., Gleitsmann, K., Koenig, H. C., Lam, C., Maltz, A., et al. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-11-201112060-00375 · Cited by 573
Metadata
- Authors
- Greene, K. L., Albertsen, P. C., Babaian, R. J., Carter, H. B., Gann, P. H., Han, M., Kuban, D. A., Sartor, A. O., Stanford, J. L., Zietman, A., & Carroll, P.
- Venue
- Journal of Urology
- Published
- 2009-11
- Volume
- 182
- Issue
- 5
- Pages
- 2232-2241
- ISSN
- 0022-5347 (ISSN-L)
- 1527-3792
- OpenAlex
- W2136804662
- Cited by
- 517
- References
- 126
- FWCI
- 57.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.